1. Home
  2. CAC vs DNA Comparison

CAC vs DNA Comparison

Compare CAC & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Camden National Corporation

CAC

Camden National Corporation

HOLD

Current Price

$43.33

Market Cap

680.5M

Sector

Finance

ML Signal

HOLD

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$8.21

Market Cap

562.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAC
DNA
Founded
1875
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
680.5M
562.3M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
CAC
DNA
Price
$43.33
$8.21
Analyst Decision
Buy
Strong Sell
Analyst Count
3
1
Target Price
$47.33
$9.00
AVG Volume (30 Days)
78.6K
1.0M
Earning Date
01-27-2026
11-06-2025
Dividend Yield
3.87%
N/A
EPS Growth
9.13
N/A
EPS
3.49
N/A
Revenue
$215,172,000.00
$180,606,000.00
Revenue This Year
$44.50
N/A
Revenue Next Year
$7.82
$7.28
P/E Ratio
$12.42
N/A
Revenue Growth
27.50
N/A
52 Week Low
$34.53
$5.00
52 Week High
$46.80
$17.58

Technical Indicators

Market Signals
Indicator
CAC
DNA
Relative Strength Index (RSI) 50.18 39.61
Support Level $43.60 $8.09
Resistance Level $46.80 $9.12
Average True Range (ATR) 0.86 0.53
MACD -0.39 0.01
Stochastic Oscillator 3.15 6.00

Price Performance

Historical Comparison
CAC
DNA

About CAC Camden National Corporation

Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: